|
Sign In to gain access to subscriptions and/or personal tools.
|
Candesartan decreases the sympatho-adrenal and hormonal response to isolation stress
Ines Armando
Section on Pharmacology, NIMH, NIH, Bethesda, MD 20892, USA, ArmandoI{at}intra.nimh.nih.gov, Centro de Investigaciones Endocrinologicas, CONICET, Buenos Aires, Argentina
Andrea Carranza
Centro de Investigaciones Endocrinologicas, CONICET, Buenos Aires, Argentina
Yasuaki Nishimura
Section on Pharmacology, NIMH, NIH, Bethesda, MD 20892, USA
Marta Barontini
Centro de Investigaciones Endocrinologicas, CONICET, Buenos Aires, Argentina
Takeshi Ito
Section on Pharmacology, NIMH, NIH, Bethesda, MD 20892, USA
Juan M Saavedra
Section on Pharmacology, NIMH, NIH, Bethesda, MD 20892, USA
A change from group housing to isolation in unfamiliar metabolic cages represents, for rodents, a significant emotional stress. We studied the effect of candesartan, a peripheral and central angiotensin II AT1-receptor antagonist, on the hormonal and sympathetic response to acute isolation. We pretreated rats with 1 mg/kg/day candesartan for 13 days via subcutaneously implanted osmotic minipumps, followed by 24-hour isolation in individual metabolic cages. We measured brain, pituitary and adrenal angiotensin II (Ang II) receptor binding by quantitative autoradiography and adrenal hormones and catecholamines by RIA and HPLC. Isolation increased adrenal catecholamines, aldosterone and corticosterone, AT1-receptor binding in the zona glomerulosa and AT2-receptor binding in the adrenal medulla. Candesartan pretreatment decreased adrenal catecholamines, aldosterone and corticosterone, AT1-receptor binding in adrenal zona glomerulosa and medulla, pituitary gland and the hypothalamic paraventricular nucleus, and AT2-receptor binding in adrenal medulla, but increased AT2-receptor binding in zona glomerulosa. We conclude that peripheral and central AT1-receptor blockade with candesartan decreases the sympatho-adrenal and hormonal response to acute stress. Our results indicate that Ang II is an important stress hormone and suggest that blockade of the physiologically active AT 1-receptors could influence stress-related disorders.
Key Words: renin-angiotensin system angiotensin receptors adrenal gland catecholamines pituitary gland corticoids brain
References
- Phillips MI, Sumners C. Angiotensin II in central nervous system physiology. Reg Peptides 1998;78:1-11.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Saavedra JM.Brain and pituitary angiotensin. Endocr Rev 1992;13:329-80.[Abstract/Free Full Text]
- Saavedra JM Emerging features of brain angiotensin receptors. Reg Peptides 1999;85:31-45.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Aguilera G., Kiss A., Luo X., Akbasak BS The renin angiotensin system and the stress response. Ann N Y Acad Sci 1995;771:173-86.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Castrén E., Saavedra JM Repeated stress increases the density of angiotensin II binding sites in the rat paraventricular nucleus and subfornical organ. Endocrinol 1988;122:370-2.[Abstract/Free Full Text]
- Castrén E., Saavedra JM Angiotensin II receptors in paraventricular nucleus, subfornical organ, and pituitary gland of hypophysectomized, adrenalectomized, and vasopressin-deficient rats. Proc Natl Acad Sci 1989;86:725-9.[Abstract/Free Full Text]
- Xang G., Xi Z-X., Wan Y., Wang H., Bi G. Changes in circulating and tissue angiotensin II during acute and chronic stress. Biol Signals 1993;2:166-72.[Medline]
[Order article via Infotrieve]
- Aguilera G., Kiss A., Luo X. Increased expression of type 1 angiotensin II receptors in the hypothalamic paraventricular nucleus following stress and glucocorticoid administration. J Neuroendocrinol 1995;7:775-83.[Web of Science][Medline]
[Order article via Infotrieve]
- Aguilera G.,Young WS, Kiss A., BathiaA. Direct regulation of hypothalamic corticotropin-releasing-hormone neurons by angiotensin II. Neuroendocrinol 1995;61:437-44.[Web of Science][Medline]
[Order article via Infotrieve]
- Sumitomo T., Suda T., Nakano Y. et al. Angiotensin II increases the corticotropin-releasing factor messenger ribonucleic acid level in the rat hypothalamus. Endocrinol 1991;128:2248-52.[Abstract/Free Full Text]
- Livett BG, Marley PD, Wan DC, Zhou XF 1990 Peptide regulation of adrenal medullary function. J Neurol Transm Suppl 1990;29:77-89.
- Vale W.,Vaughan J., Smith M.,Yamamoto G., Rivier J., Rivier C. Interaction between CRF and angiotensin II in control of ACTH and adrenal steroids. Am J Physiol 1983;250:R396-R402.
- Inagami T., Guo DF, Kitami Y. Molecular biology of angiotensin II receptors: an overview. J Hypertens 1994;12 Suppl:S83-S94.[Web of Science]
- Timmermans P., Wong PC, Chiu AT et al. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 1993;45:205-51.[Web of Science][Medline]
[Order article via Infotrieve]
- Tsutsumi K., Saavedra JMAngiotensin II receptor subtypes in median eminence and basal forebrain areas involved in regulation of pituitary function. Endocrinol 1991;129:3001-8.[Abstract/Free Full Text]
- Heemskerk FMJ, Saavedra JM Quantitative autoradiography of angiotensin II AT2 receptors with [125I]CGP 42112. Brain Res 1995;677:29-38.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Jöhren O., Inagami T., Saavedra JM AT1A, AT1B, and AT2 angiotensin II receptor subtype gene expression in rat brain. Neuro-Report 1995;6:2549-52.[Web of Science][Medline]
[Order article via Infotrieve]
- Jöhren O., Inagami T., Saavedra JM Localization of AT2 angiotensin II receptor gene expression in rat brain by in situ hybridization histochemistry. Mol Brain Res 1996;37:192-200.[Medline]
[Order article via Infotrieve]
- Tsutsumi K., Strömberg C., Viswanathan M., Saavedra JM Angiotensin-II receptor subtypes in fetal tissues of the rat: autoradiography, guanine nucleotide sensitivity, and association with phosphoinositide hydrolysis. Endocrinol 1991;129:1075-82.[Abstract/Free Full Text]
- Inagami T., Eguchi S., Numaguchi K. et al. Cross-talk between angiotensin II receptors and the tyrosine kinases and phosphatases. J Am Soc Nephrol 1999; 10:S57-S61.[Web of Science][Medline]
[Order article via Infotrieve]
- De Gasparo M., Siragy, HMThe AT2 receptor: fact, fancy and fantasy. Reg Peptides 1999; 81:11-24.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Armando I., Nowicki S.,Aguirre J., Barontini M. A decreased tubular uptake of dopa results in defective renal dopamine production in aged rats.AmJPhysiol 1995;268: F1087-F1092.[Web of Science][Medline]
[Order article via Infotrieve]
- Tsutsumi K., Saavedra JM Characterization and development of angiotensin II receptor subtypes (AT1 and AT2) in rat brain. Am J Physiol 1991;261:R209-R216.[Web of Science][Medline]
[Order article via Infotrieve]
- Nazarali AJ, Gukind JS, Saavedra JM Calibration of [125I]-polymer standards with [125I]-brain paste standards for use in quantitative receptor autoradiography. J Neurosci Methods 1989;30:247-53.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Grima B., Lamouroux A., Blanot F., Biguet NF, Mallet J. Complete coding sequence of rat tyrosine hydroxylase mRNA. Proc Natl Acad Sci USA 1985;82:617-21.[Abstract/Free Full Text]
- Wisden W., Morris BJ In situ hybridization with synthetic oligonucletide probes. In:W.Wisden and BJ Morris. (eds) In situ hybridization protocols for the brain. Academic Press Inc: San Diego, CA, USA, 1994:9-34.
- Misslin R., Herzog F., Koch B., Ropartz P. Effects of isolation, handling and novelty on the pituitary-adrenal response in the mouse. Psychoneuroendocrinol 1982;7:217-22.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Horie R., Yamori Y., Nara Y., Sawamura M., Mizushima S. Aggravating effects of isolated caging on the development of hypertension and its complications in stroke-prone spontaneously hypertensive rats (SHRSP) and Wistar-Kyoto rats (WKY). Clin and Exper Hyper-Theory and Practice A 1991; 13:859-64.
- Moore KE Studies with chronically isolated rats: tissue levels and urinary excretion of catecholamines and plasma levels of corticosterone. Can J Phys Pharm 1968;46:553-8.[Web of Science][Medline]
[Order article via Infotrieve]
- Aguilera, G. Factors controlling steroid biosynthesis in the zona glomerulosa of the adrenal. J Steroid Biochem Molec Biol 1993;45:147-51.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Naruse M., Tanabe A., Sugaya T. et al. Differential roles of angiotensin receptor subtypes in adrenocortical function in mice. Life Sci 1998;63:1593-8.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Wong PC, Hart SD, Zaspel AM et al. Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands. Dup 753 (AII-1) and PD 123177 (AII-2). J Pharm Exp Ther 1990;255:584-92.[Abstract/Free Full Text]
- Belloni AS, Andreis PG, Macchi V. et al. Distribution and functional significance of angiotensin-II AT1 and AT2 receptor subtypes in the rat adrenal gland. Endocr Res 1998;24:1-15.[Web of Science][Medline]
[Order article via Infotrieve]
- Israel A., Strömberg C., Tsutsumi K., Garrido MR, Torres M., Saavedra JM Angiotensin II receptor subtypes and phosphoinositide hydrolysis in rat adrenal medulla. Brain Res Bull 1995;38:441-6.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Sever PS Key features of candesartan cilexetil and a comparison with other angiotensin II receptor antagonists. J Human Hypertension 1999;13(Suppl 1): S3-S10.
- Balla T., Baukal AJ, Eng, S., Catt, KJ Angiotensin II receptor subtypes and biological responses in the adrenal cortex and medulla. Mol Pharm 1991;40:401-6.[Abstract]
- Nishimura Y., Ito T., Hoe K.-L, Saavedra JM Chronic peripheral administration of the angiotensin II AT1 receptor antagonist Candesartan blocks brain AT1 receptors. Brain Res 2000; 871:29-38.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Jezova D., Ochedalski T., Kiss A., Aguilera G. Brain angiotensin II modulates sympathoadrenal and hypothalamic pituitary adrenocortical activation during stress. J Neuroendocrinol 1998;10:67-72.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Polidori C., Ciccocioppo R., Nisato R., Cazaubon C., Massi M. Evaluation of the ability of irbesartan to cross the blood-brain barrier following acute intragastric treatment. Eur J Pharm 1998;352:15-21.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Bui JD, Kimura B., Phillips MI Losartan potassium, a nonpeptide antagonist of angiotensin II, chronically administered p.o. does not readily cress the blood brain barrier. Eur J Pharmacol 1992;219:147-51.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
Journal of Renin-Angiotensin-Aldosterone System, Vol. 2, No. 1 suppl,
S130-S135 (2001)
DOI: 10.1177/14703203010020012301

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|